AskBio spins out new gene therapy company, Actus Therapeutics – WRAL Tech Wire
WRAL Tech Wire |
AskBio spins out new gene therapy company, Actus Therapeutics
WRAL Tech Wire CHAPEL HILL – Asklepios BioPharmaceutical (AskBio), a gene therapy platform company based in Chapel Hill, has spun out its fourth company, Actus Therapeutics, to develop gene therapies for rare genetic diseases including Pompe disease and epilepsy … |
